These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14129058)

  • 1. HYPERALDOSTERONISM AND RENAL SODIUM LOSS REVERSED BY DRUG TREATMENT FOR MALIGNANT HYPERTENSION.
    GILL JR; GEORGE JM; SOLOMON A; BARTTER FC
    N Engl J Med; 1964 May; 270():1088-92. PubMed ID: 14129058
    [No Abstract]   [Full Text] [Related]  

  • 2. [ACUTE MALIGNANT HYPERTENSION WITH SECONDARY ALDOSTERONISM. A CASE IN A 31-YEAR-OLD MAN WITH CONGENITAL UNILATERAL RENAL HYPOPLASIA].
    PEDERSEN J; LINDENEG O; FISCHER S
    Ugeskr Laeger; 1964 Jan; 126():73-8. PubMed ID: 14115392
    [No Abstract]   [Full Text] [Related]  

  • 3. HYPERTENSION AND HYPERALDOSTERONISM OF RENAL AND ADRENAL ORIGIN.
    SLATON PE; BIGLIERI EG
    Am J Med; 1965 Mar; 38():324-36. PubMed ID: 14266825
    [No Abstract]   [Full Text] [Related]  

  • 4. FLUID RETENTION PRODUCED BY GUANETHIDINE; CHANGES IN BODY EXCHANGEABLE SODIUM, BLOOD VOLUME, AND CREATININE CLEARANCE.
    SMITH AJ
    Circulation; 1965 Apr; 31():490-6. PubMed ID: 14275986
    [No Abstract]   [Full Text] [Related]  

  • 5. INTERACTION BETWEEN ALDOSTERONE SECRETION, SODIUM AND POTASSIUM BALANCE, AND ANGIOTENSIN ACTIVITY IN MAN: STUDIES IN HYPERTENSION AND CIRRHOSIS.
    LARAGH JH; CANNON PJ; AMES RP
    Can Med Assoc J; 1964 Jan; 90(4):248-56. PubMed ID: 14111729
    [No Abstract]   [Full Text] [Related]  

  • 6. [MALIGNANT HYPERTENSION].
    CHIRONE E
    Policlinico Prat; 1964 Mar; 71():325-38. PubMed ID: 14143292
    [No Abstract]   [Full Text] [Related]  

  • 7. BILATERAL RENAL ARTERY STENOSIS WITH ALDOSTERONISM.
    BLAGG CR; GLANVILLE JN
    Br J Radiol; 1964 Jul; 37():554-7. PubMed ID: 14196799
    [No Abstract]   [Full Text] [Related]  

  • 8. Dietary sodium restriction and natriuresis in management of hypertension.
    Mashaly M; el-Ebrashy N; Higazi AM; el-Din Moustafa S; Abul-Einen M
    J Egypt Med Assoc; 1974; 57(1-2):41-8. PubMed ID: 4452751
    [No Abstract]   [Full Text] [Related]  

  • 9. THE EFFECT OF SOME HYPOTENSIVE AGENTS ON RENAL PLASMA FLOW IN THE UNANESTHETIZED DOG.
    WAGLE GL; PLUMMER AJ
    Arch Int Pharmacodyn Ther; 1964 Sep; 151():76-85. PubMed ID: 14208174
    [No Abstract]   [Full Text] [Related]  

  • 10. EXPERIENCES WITH THE LONG-TERM USE OF METHYLDOPA ("ALDOMET") IN HYPERTENSION.
    MEIRING PD
    Med J Aust; 1965 Mar; 1(12):416-9. PubMed ID: 14274397
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent advances in the medical and surgical treatment of hypertension.
    Tucker RM; Hunt JC
    Med Clin North Am; 1968 Sep; 52(5):1227-36. PubMed ID: 4876836
    [No Abstract]   [Full Text] [Related]  

  • 12. CARDIAC AND RENAL HYPERRESPONSIVENESS TO ACUTE PLASMA VOLUME EXPANSION IN HYPERTENSION.
    ULRYCH M; HOFMAN J; HEJL Z
    Am Heart J; 1964 Aug; 68():193-203. PubMed ID: 14204314
    [No Abstract]   [Full Text] [Related]  

  • 13. [CONSIDERATIONS ON THE RENAL SIDE-EFFECTS DURING TREATMENT OF ARTERIAL HYPERTENSION].
    MIHAILESCU VV; CLEJ V; ENESCU R; SBENGHE S
    Med Interna (Bucur); 1964 Jan; 16():79-82. PubMed ID: 14132694
    [No Abstract]   [Full Text] [Related]  

  • 14. [PATHOPHYSIOLOGY AND CLINICAL ASPECTS OF SECONDARY ALDOSTERONISM AND ITS TREATMENT].
    HOFFMEISTER W
    Folia Clin Int (Barc); 1964 Mar; 14():124-44. PubMed ID: 14153959
    [No Abstract]   [Full Text] [Related]  

  • 15. [APPLICATION OF HYPOTHIAZIDE IN CHRONIC KIDNEY DISEASES].
    SHULGA IuD
    Sov Med; 1963 Aug; 27():110-2. PubMed ID: 14088097
    [No Abstract]   [Full Text] [Related]  

  • 16. [EFFECTS OF NORETHISTERONE ACETATE ON THE RENAL EXCRETION OF SODIUM, POTASSIUM AND WATER IN NORMAL INDIVIDUALS].
    BRADFORD I; GOMEZ RE; GENERINI G
    Rev Med Chil; 1963 Aug; 91():583-5. PubMed ID: 14090114
    [No Abstract]   [Full Text] [Related]  

  • 17. ALDOSTERONE SECRETION RATE AND ELECTROLYTE BALANCE STUDIES ON THREE PATIENTS WITH HYPERTENSION. INFLUENCE OF GUANETHIDINE, HYDRALAZINE AND METHYCLOTHIAZIDE.
    SAMBHI MP; VENNING EH; BECK JC
    Metabolism; 1964 Mar; 13():212-20. PubMed ID: 14127688
    [No Abstract]   [Full Text] [Related]  

  • 18. NATURE OF RENAL ESCAPE FROM THE SODIUM-RETAINING EFFECT OF ALDOSTERONE IN PRIMARY ALDOSTERONISM AND IN NORMAL SUBJECTS.
    ROVNER DR; CONN JW; KNOPF RF; COHEN EL; HSUEH MT
    J Clin Endocrinol Metab; 1965 Jan; 25():53-64. PubMed ID: 14252288
    [No Abstract]   [Full Text] [Related]  

  • 19. PLASMA RENIN IN A CASE OF CONN'S SYNDROME WITH FIBRINOID LESIONS: USE OF SPINONOLACTONE IN TREATMENT.
    BROWN JJ; DAVIES DL; LEVER AF; PEART WS; ROBERTSON JI
    Br Med J; 1964 Dec; 2(5425):1636-7. PubMed ID: 14213078
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combined treatment of arterial hypertension (guanethidine, hydralazine, reserpine, saluretics)].
    CABROL RA
    Sem Med; 1962 Apr; 120():652-6. PubMed ID: 13875430
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.